COPD: is there light at the end of the tunnel? - PubMed (original) (raw)

Review

COPD: is there light at the end of the tunnel?

Peter J Barnes. Curr Opin Pharmacol. 2004 Jun.

Abstract

No currently available treatments reduce the progression or suppress the inflammation of chronic obstructive pulmonary disease (COPD). However, with a better understanding of the inflammatory and destructive process, several targets have been identified and new treatments are in clinical development. Several specific therapies are directed against the influx of inflammatory cells into the airways and lung parenchyma that occurs in COPD, including adhesion molecule and chemokine-directed therapy, as well as therapies to inhibit tumour necrosis factor-alpha. Several broad-spectrum anti-inflammatory drugs are also in development, and include inhibitors of phosphodiesterase-4, p38 mitogen-activated protein kinase and nuclear factor-kappaB. There is a need for validated biomarkers and monitoring techniques in early clinical studies with new therapies for COPD.

PubMed Disclaimer

Cited by

TRPM2-mediated Ca2+influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration.
Yamamoto S, Shimizu S, Kiyonaka S, Takahashi N, Wajima T, Hara Y, Negoro T, Hiroi T, Kiuchi Y, Okada T, Kaneko S, Lange I, Fleig A, Penner R, Nishi M, Takeshima H, Mori Y. Yamamoto S, et al. Nat Med. 2008 Jul;14(7):738-47. doi: 10.1038/nm1758. Epub 2008 Jun 8. Nat Med. 2008. PMID: 18542050 Free PMC article.
Identifying targets for COPD treatment through gene expression analyses.
Chen ZH, Kim HP, Ryter SW, Choi AM. Chen ZH, et al. Int J Chron Obstruct Pulmon Dis. 2008;3(3):359-70. doi: 10.2147/copd.s1758. Int J Chron Obstruct Pulmon Dis. 2008. PMID: 18990963 Free PMC article. Review.
Measuring the impact of a live, case-based, multiformat, interactive continuing medical education program on improving clinician knowledge and competency in evidence-based COPD care.
Drexel C, Jacobson A, Hanania NA, Whitfield B, Katz J, Sullivan T. Drexel C, et al. Int J Chron Obstruct Pulmon Dis. 2011;6:297-307. doi: 10.2147/COPD.S18257. Epub 2011 May 23. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 21697994 Free PMC article.
Longitudinal changes in structural abnormalities using MDCT in COPD: do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression?
Takayanagi S, Kawata N, Tada Y, Ikari J, Matsuura Y, Matsuoka S, Matsushita S, Yanagawa N, Kasahara Y, Tatsumi K. Takayanagi S, et al. Int J Chron Obstruct Pulmon Dis. 2017 Feb 13;12:551-560. doi: 10.2147/COPD.S121405. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28243075 Free PMC article.
Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblasts.
La Rocca G, Anzalone R, Magno F, Farina F, Cappello F, Zummo G. La Rocca G, et al. Respir Res. 2007 Mar 12;8(1):23. doi: 10.1186/1465-9921-8-23. Respir Res. 2007. PMID: 17352820 Free PMC article.

COPD: is there light at the end of the tunnel? - PubMed (original) (raw)